Enact Holdings Inc vs Canopy Growth Corp — how do they compare? Enact Holdings Inc trades at $49.07 (market cap $6.67B), while Canopy Growth Corp trades at $0.99 (market cap $399.40M). The key difference: Enact Holdings Inc is far larger — about 16.7× Canopy Growth Corp's market cap, and Enact Holdings Inc pays a 1.98% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| ACT | CGC | |
|---|---|---|
Market Cap | $6.67B | $399.40M |
Sector | Technology | Health |
52-Week High | $49.12 | $1.92 |
52-Week Low | $34.93 | $0.86 |
Enterprise Value | $6.96B | $356.90M |
Dividend Yield | 1.98% | — |
Signals from Pluang's Aura AI — not financial advice
ACT trades at $48.96, up 0.6% today, near the consensus price target of $49.00. The stock shows strong fundamentals with a P/E of 10.23 and robust net income margin of 54.51%. Recent Q2 2026 earnings beat expectations at $1.26 per share. Technical indicators signal a bullish trend with moving averages supporting upside momentum. The company maintains consistent dividend payments and positive revenue growth projections.
Outlook remains positive with analyst consensus favoring buy/hold ratings and price targets suggesting limited upside. Key risks include execution challenges and market volatility. Earnings growth and dividend consistency provide support, but investors should monitor competitive pressures and macroeconomic factors that could impact performance.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Enact Holdings is a leading private mortgage insurance provider in the U.S. It partners with lenders to offer credit enhancement and risk management solutions, helping more borrowers achieve and maintain homeownership.
Read more on ACT →Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →